Rutherford Colin 4
4 · Evofem Biosciences, Inc. · Filed Mar 14, 2018
Insider Transaction Report
Form 4
Rutherford Colin
Director
Transactions
- Award
Stock option (right to buy)
2018-03-12+15,000→ 15,000 totalExercise: $7.29Exp: 2028-03-12→ Common Stock (15,000 underlying) - Award
Stock option (right to buy)
2018-03-12+24,691→ 24,691 totalExercise: $7.29Exp: 2028-03-12→ Common Stock (24,691 underlying)
Footnotes (2)
- [F1]Mr. Rutherford acquired a vested interest in one hundred percent (100%) of the shares of common stock exercisable pursuant to the option effective as of March 12, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from March 12, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.